Dmukauskas, M., Cioffi, G., Neff, C., Price, M., Waite, K. A., Kruchko, C., … Barnholtz-Sloan, J. S. (2023). Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors. Neurooncol Adv, 5(1), vdad022. https://doi.org/10.1093/noajnl/vdad022

Dmukauskas, Mantas, Gino Cioffi, Corey Neff, Mackenzie Price, Kristin A. Waite, Carol Kruchko, Justin M. Barnes, Quinn T. Ostrom, and Jill S. Barnholtz-Sloan. “Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors.” Neurooncol Adv 5, no. 1 (2023): vdad022. https://doi.org/10.1093/noajnl/vdad022.

Dmukauskas M, Cioffi G, Neff C, Price M, Waite KA, Kruchko C, et al. Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors. Neurooncol Adv. 2023;5(1):vdad022.

Dmukauskas, Mantas, et al. “Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors.” Neurooncol Adv, vol. 5, no. 1, 2023, p. vdad022. Pubmed, doi:10.1093/noajnl/vdad022.

Dmukauskas M, Cioffi G, Neff C, Price M, Waite KA, Kruchko C, Barnes JM, Ostrom QT, Barnholtz-Sloan JS. Medicaid expansion is associated with increased 1-year survival for primary malignant brain tumors. Neurooncol Adv. 2023;5(1):vdad022.